In the News


Potential new class of drugs may reduce cardiovascular risk by targeting gut microbes

Developed at Cleveland Clinic, the non-antibiotic compounds, tested in animal models, prevented production of gut byproduct linked to heart attack and stroke in humans


Ohio and heartland must embrace the "innovation economy," report says

When it comes to taking advantage of the so-called "innovation-based economy," where does Ohio rank? 


Plug and Play stops in Cleveland

In Spring 2018, Plug and Play Cleveland Innovation Platform began its first inaugural Health & Wellness accelerator program.

Plug and Play started with about one-thousand candidates and then narrowed down that list to 50. They shared that list with the Cleveland Clinic and JumpStart and then arrived at 13 companies.


ClearFlow Announces Additional Positive US Clinical Trial Results at the 2018 NTI Critical Care Exposition

ClearFlow, Inc., a medical device company based in Anaheim, California, has announced that positive clinical trial results were presented at the National Teaching Institute (NTI) & Critical Care Exposition 2018 annual meeting on May 23rd, 2018 in Boston, MA. The findings were presented by the study principal investigator, Dr. Yvon Baribeau, of Catholic Medical Center in Manchester, New Hampshire, in a presentation titled “Active Clearance of Chest Drains Reduces Pleural Effusions and ICU Resources in patients undergoing Cardiac Surgery.”


NaviGate Cardiac Structures Inc. (“NCSI”) reports “excellent valvular function” at 1-year follow-up of first patient to receive GATE™ tricuspid valved stent via transjugular access

NaviGate Cardiac Structures Inc. (“NCSI”) announced today that the first patient to receive its replacement tricuspid valved stent via transjugular access has reached one-year post-procedure with excellent valvular function. This patient, along with 15 others treated to date under compassionate use protocols for severe tricuspid regurgitation, have received NCSI’s GATE™ tricuspid valved stent designed to lead to restored valvular function and improved quality of life.


Cleveland Clinic innovation team shares strategic formula for tech transformation

Wouldn’t you like a look inside the Cleveland Clinic’s innovation mindset? Attendees at the HIMSS and Health 2.0 Dev4Health event here this week got just such a glimpse.


ClearFlow Reports: ERAS Cardiac Surgery Recommends Active Tube Clearance Methodology in Consensus Statement Presented at the 98th Annual Meeting of The American Association for Thoracic Surgeons

ClearFlow Inc. has announced that an international society of leading heart surgeons known as ERAS® Cardiac Surgery presented evidenced-based expert consensus statements at the 98th annual meeting of the American Association for Thoracic Surgeons on April 28, 2018. Amongst key recommendations to promote enhanced patient outcomes after cardiac surgery is the use of Active Clearance techniques to maintain chest tube patency. The PleuraFlow® ACT® System is the only FDA cleared device with the indication to prevent or minimize retained blood in patients recovering from heart surgery.


Dev4Health conference examines how data sharing improves health care for patients, doctors

The health care industry is converging on ways for designers to create software that helps patients stay healthy and doctors deliver better and cheaper health care. It's a concept that's taking place at the Dev4Health conference downtown.


And let there be innovation!

Innovation in healthcare will bring with it innovation in the way healthcare is consumed and delivered. The emphasis on innovation will drive more efficient technology-enabled care models, integrated delivery designs which are tailor made to meet the specific needs of the patient.


2nd Annual Medical Capital Innovation Competition Winners Announced

BioEnterprise, in partnership with the Global Center for Health Innovation (Global Center), Cuyahoga County, and Healthcare Information and Management Systems Society (HIMSS) is pleased to announce the winners of the second annual Medical Capital Innovation Competition, “The Next Generation of Healthcare”:

   < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >   

Get In Touch With Us